Walleye Capital LLC Sells 32,199 Shares of Schrödinger, Inc. (NASDAQ:SDGR)

Walleye Capital LLC lowered its position in Schrödinger, Inc. (NASDAQ:SDGRGet Rating) by 62.4% during the 1st quarter, Holdings Channel reports. The firm owned 19,425 shares of the company’s stock after selling 32,199 shares during the quarter. Walleye Capital LLC’s holdings in Schrödinger were worth $663,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of SDGR. Bank of America Corp DE grew its stake in Schrödinger by 17.3% in the fourth quarter. Bank of America Corp DE now owns 64,835 shares of the company’s stock worth $2,259,000 after purchasing an additional 9,555 shares in the last quarter. Dimensional Fund Advisors LP bought a new stake in Schrödinger during the 4th quarter valued at $2,833,000. Teacher Retirement System of Texas boosted its position in Schrödinger by 23.8% during the 4th quarter. Teacher Retirement System of Texas now owns 9,617 shares of the company’s stock valued at $335,000 after acquiring an additional 1,846 shares in the last quarter. Qube Research & Technologies Ltd boosted its position in Schrödinger by 148.2% during the 4th quarter. Qube Research & Technologies Ltd now owns 9,740 shares of the company’s stock valued at $339,000 after acquiring an additional 5,815 shares in the last quarter. Finally, Ensign Peak Advisors Inc bought a new stake in Schrödinger during the 4th quarter valued at $250,000. Institutional investors own 65.45% of the company’s stock.

Analyst Ratings Changes

Several analysts have issued reports on SDGR shares. Piper Sandler increased their target price on Schrödinger from $84.00 to $86.00 and gave the company an “overweight” rating in a research report on Tuesday, July 26th. Morgan Stanley increased their target price on Schrödinger from $33.00 to $39.00 and gave the company an “equal weight” rating in a research report on Friday, September 9th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $67.17.

Schrödinger Price Performance

Schrödinger stock opened at $26.81 on Wednesday. The stock has a market capitalization of $1.91 billion, a price-to-earnings ratio of -12.95 and a beta of 1.17. Schrödinger, Inc. has a 1-year low of $20.71 and a 1-year high of $61.00. The business has a fifty day moving average price of $29.88 and a 200-day moving average price of $28.95.

Schrödinger (NASDAQ:SDGRGet Rating) last posted its quarterly earnings data on Thursday, August 4th. The company reported ($0.62) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.61) by ($0.01). The business had revenue of $38.50 million during the quarter, compared to analyst estimates of $35.48 million. Schrödinger had a negative return on equity of 26.65% and a negative net margin of 90.62%. The firm’s revenue for the quarter was up 29.2% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.49) EPS. On average, equities research analysts anticipate that Schrödinger, Inc. will post -2.22 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Nancy Thornberry sold 4,950 shares of the firm’s stock in a transaction on Thursday, August 11th. The stock was sold at an average price of $35.00, for a total value of $173,250.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 5.90% of the stock is currently owned by company insiders.

Schrödinger Company Profile

(Get Rating)

Schrödinger, Inc, together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries.

See Also

Want to see what other hedge funds are holding SDGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Schrödinger, Inc. (NASDAQ:SDGRGet Rating).

Institutional Ownership by Quarter for Schrödinger (NASDAQ:SDGR)

Receive News & Ratings for Schrödinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrödinger and related companies with MarketBeat.com's FREE daily email newsletter.